Clinical and Immunological Outcomes of Living and Deceased Donor Transplantation
Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Dec 30, 2024
Trial Information
Current as of July 04, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the long-term health of kidney transplant recipients, focusing on how the type of donor—whether a living person or someone who has passed away—affects the success of the transplant. The study aims to gather information to understand better how these different donor sources influence kidney function over time.
To participate in this trial, individuals need to be at least 18 years old and have received a kidney transplant from any type of donor. Participants will be asked to provide their consent to take part in the study and allow their data to be used for research purposes. This is an observational study, meaning that researchers will be collecting information without any new treatments being given. If you join, you can expect to help contribute to important findings that may improve future kidney transplant outcomes, and your experience will help researchers understand the best donor options for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years.
- • Kidney transplant recipient from any donor.
- • Acquisition of Informed Consent to study participation and data processing.
- Exclusion Criteria:
- • -
About Irccs Azienda Ospedaliero Universitaria Di Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, Bo, Italy
Patients applied
Trial Officials
Giorgia Comai, MD
Principal Investigator
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported